Chengda Biotech (688739.SH): Shaoguan Gaoteng's offer expires and trading suspended for 1 trading day on April 7

Zhitong Finance App News, Chengda Biotech (688739.SH) announced that on March 3, 2025, the company disclosed the “Liaoning Chengda Biotech Co., Ltd. Offer Report”. Shaoguan Gaoteng issued a comprehensive offer to all shareholders of Chengda Biotech other than Liaoning Chengda Co., Ltd. to acquire tradable shares held by Chengda Biotech with unlimited conditions of sale. The number of shares scheduled to be purchased was 183,971,587 shares, accounting for 44.18% of the company's total share capital. The offer period is from March 5, 2025 to April 3, 2025.

As of April 3, 2025, the term of the tender offer expires. Due to the need to further confirm the results of the offer, in accordance with the “Shanghai Stock Exchange Listed Companies Self-Regulatory Guidelines No. 4 - Suspension and Resumption of Trading” and “Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules” and other relevant regulations, after applying to the Shanghai Stock Exchange, the company's shares were suspended for one trading day on April 7, 2025 (Monday), and trading will resume on the day the Tender Results are announced.